Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and immunogenicity of a lyophilized herpes zoster virus mRNA vaccine, sponsored by Sinovac Biotech Co., Ltd, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Lyophilized Herpes Zoster Virus mRNA Vaccine (Lyophilized Herpes Zoster Virus mRNA Vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Herpes Zoster, mRNA Vaccine | Phase 1, Phase 2 | Status: RECRUITING